Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

Eur Heart J Cardiovasc Pharmacother · 2023 · PMC9892867 · PMID 36639130

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline non-significantno p-value reported

placebo, the between-group differences for all-cause mortality and CV mortality were borderline non-significant (i.e. upper bounds of the 95% CI just over unity).

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.